Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 46.14%-59.47M | ---- | -94.64%-110.4M | ---- | -732.76%-56.72M | ---- | -84.26%8.96M | ---- | -21.41%56.94M |
| Profit adjustment | ||||||||||
| Attributable subsidiary (profit) loss | ---- | 714.88%6.03M | ---- | ---981K | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | -48.19%38.67M | ---- | 60.96%74.64M | ---- | 89.97%46.37M | ---- | 50.58%24.41M | ---- | 356.01%16.21M |
| -Other impairments and provisions | ---- | -48.19%38.67M | ---- | 60.96%74.64M | ---- | 89.97%46.37M | ---- | 50.58%24.41M | ---- | 356.01%16.21M |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -217.81%-1.46M |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -217.81%-1.46M |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -68.72%56K | ---- | --179K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -68.72%56K | ---- | --179K |
| Depreciation and amortization: | ---- | -2.29%7.8M | ---- | 5.30%7.99M | ---- | 9.76%7.58M | ---- | 22.13%6.91M | ---- | 39.99%5.66M |
| -Amortization of intangible assets | ---- | 10.81%2.05M | ---- | -15.83%1.85M | ---- | 61.97%2.2M | ---- | 26.59%1.36M | ---- | 48.48%1.07M |
| Financial expense | ---- | -2.25%1.78M | ---- | 9.83%1.82M | ---- | -16.93%1.66M | ---- | 45.69%2M | ---- | 2.62%1.37M |
| Exchange Loss (gain) | ---- | -93.16%80K | ---- | 51.36%1.17M | ---- | 154.94%773K | ---- | -199.86%-1.41M | ---- | 289.38%1.41M |
| Special items | ---- | -61.75%2.49M | ---- | --6.52M | ---- | ---- | ---- | -724.88%-2.69M | ---- | -6.72%430K |
| Operating profit before the change of operating capital | ---- | 86.45%-2.61M | ---- | -5,663.17%-19.25M | ---- | -100.87%-334K | ---- | -52.63%38.24M | ---- | -1.95%80.74M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 200.49%2.49M | ---- | -11.74%-2.47M | ---- | -90.21%-2.21M | ---- | 55.44%-1.16M | ---- | -962.05%-2.61M |
| Accounts receivable (increase)decrease | ---- | 117.45%5.45M | ---- | -521.28%-31.24M | ---- | -108.23%-5.03M | ---- | 191.84%61.14M | ---- | 20.18%-66.57M |
| Accounts payable increase (decrease) | ---- | 96.11%-1.96M | ---- | -3,137.74%-50.31M | ---- | -91.25%1.66M | ---- | 180.14%18.93M | ---- | -138.57%-23.62M |
| Special items for working capital changes | ---- | -105.34%-6.18M | ---- | 1,256.07%115.86M | ---- | 106.21%8.54M | ---- | -452.39%-137.69M | ---- | 29.84%-24.93M |
| Cash from business operations | ---- | -122.31%-2.81M | ---- | 380.02%12.59M | ---- | 112.76%2.62M | ---- | 44.44%-20.55M | ---- | -248.35%-36.99M |
| Other taxs | ---- | ---- | ---- | ---520K | ---- | ---- | ---- | -60.11%-2.26M | ---- | -159.45%-1.41M |
| Special items of business | 985.25%9.24M | ---- | 29.84%-1.04M | ---- | -22.87%-1.49M | ---- | 97.51%-1.21M | ---- | -2,755.78%-48.69M | ---- |
| Net cash from operations | 985.25%9.24M | -123.27%-2.81M | 29.84%-1.04M | 360.20%12.07M | -22.87%-1.49M | 111.50%2.62M | 97.51%-1.21M | 40.59%-22.81M | -2,755.78%-48.69M | -257.46%-38.4M |
| Cash flow from investment activities | ||||||||||
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | 19,160.00%963K | ---- | -50.00%5K | ---- | --10K |
| Purchase of fixed assets | ---- | 85.85%-609K | ---- | -10,933.33%-4.3M | ---- | 99.46%-39K | ---- | -7.02%-7.24M | ---- | 10.12%-6.76M |
| Purchase of intangible assets | ---- | 22.78%-61K | ---- | 96.46%-79K | ---- | 75.13%-2.23M | ---- | -236.37%-8.97M | ---- | 56.93%-2.67M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---78K | ---- | ---- |
| Other items in the investment business | ---- | ---- | -462.96%-152K | ---- | 97.82%-27K | ---- | 87.96%-1.24M | ---- | -384.61%-10.26M | ---- |
| Net cash from investment operations | ---- | 84.71%-670K | -462.96%-152K | -235.27%-4.38M | 97.82%-27K | 91.97%-1.31M | 87.96%-1.24M | -72.84%-16.28M | -384.61%-10.26M | 49.67%-9.42M |
| Net cash before financing | 872.74%9.24M | -145.25%-3.48M | 21.06%-1.2M | 484.27%7.69M | 38.09%-1.52M | 103.37%1.32M | 95.85%-2.45M | 18.25%-39.1M | -1,442.11%-58.96M | -943.18%-47.83M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -9.18%26.14M | ---- | 27.76%28.78M | ---- | -53.50%22.53M | ---- | 73.74%48.44M | ---- | 20.91%27.88M |
| Refund | ---- | 30.98%-20.9M | ---- | -16.85%-30.27M | ---- | 30.45%-25.91M | ---- | -42.44%-37.25M | ---- | -107.42%-26.15M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --75.8M |
| Interest paid - financing | ---- | 2.25%-1.78M | ---- | -9.83%-1.82M | ---- | 16.93%-1.66M | ---- | -45.69%-2M | ---- | -2.62%-1.37M |
| Absorb investment income | ---- | ---- | ---- | --100K | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -329.53%-17.6M |
| Pledged bank deposit (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 312.74%2.32M |
| Other items of the financing business | -895.42%-12.17M | ---- | -59.22%1.53M | ---- | 224.98%3.75M | ---- | -108.41%-3M | ---- | 564.86%35.72M | ---- |
| Net cash from financing operations | -895.42%-12.17M | 155.86%2.45M | -59.22%1.53M | 29.83%-4.39M | 224.98%3.75M | -177.01%-6.25M | -108.41%-3M | -86.45%8.12M | 564.86%35.72M | 337.68%59.93M |
| Effect of rate | -117.04%-151K | 433.33%20K | 203.26%886K | 93.18%-6K | -165.95%-858K | -115.74%-88K | 204.00%1.3M | 144.86%559K | -451.40%-1.25M | -267.47%-1.25M |
| Net Cash | -976.65%-2.93M | -131.14%-1.03M | -85.07%334K | 166.86%3.3M | 141.05%2.24M | 84.06%-4.94M | 76.55%-5.45M | -355.97%-30.98M | -101.98%-23.24M | -37.50%12.1M |
| Begining period cash | -19.48%4.17M | 175.36%5.17M | 175.36%5.17M | -72.78%1.88M | -72.78%1.88M | -81.50%6.9M | -81.50%6.9M | 41.02%37.32M | 41.02%37.32M | 316.26%26.47M |
| Cash at the end | -83.00%1.09M | -19.48%4.17M | 96.26%6.39M | 175.36%5.17M | 18.21%3.26M | -72.78%1.88M | -78.52%2.76M | -81.50%6.9M | -16.22%12.83M | 41.02%37.32M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
| Auditor | -- | Zhongrui Hexin Certified Public Accountants Co., Ltd. | -- | Zhongrui Hexin Certified Public Accountants Co., Ltd. | -- | Zhongrui Hexin Certified Public Accountants Co., Ltd. | -- | Zhongrui Hexin Certified Public Accountants Co., Ltd. | -- | Zhongrui Hexin Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.